Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01PGU
|
|||
| Former ID |
DNC000031
|
|||
| Drug Name |
15-deoxy-Delta(12, 14)-prostaglandin J(2)
|
|||
| Synonyms |
15d-PGJ2; 15-Deoxy-PGJ2; 15-Deoxy-delta-12,14-prostaglandin J2; 15-deoxy-delta12,14-prostaglandin J2; delta12,14-PGJ 2; UNII-ALI977775J; 87893-55-8; CHEMBL482477; CHEBI:34159; (5Z,12E,14E)-11-oxoprosta-5,9,12,14-tetraen-1-oic acid; ALI977775J; delta-12,14-15-Deoxy-PGJ2; 15-Deoxy-delta12,14-prostaglandin; 15-deoxy-Delta(12,14)-prostaglandin J2; Prostaglandin J2, 15-Deoxy-Delta12,14; 15-Deoxy-delta 12, 14-Prostaglandin J2
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C20H28O3
|
|||
| Canonical SMILES |
CCCCCC=CC=C1C(C=CC1=O)CC=CCCCC(=O)O
|
|||
| InChI |
1S/C20H28O3/c1-2-3-4-5-6-10-13-18-17(15-16-19(18)21)12-9-7-8-11-14-20(22)23/h6-7,9-10,13,15-17H,2-5,8,11-12,14H2,1H3,(H,22,23)/b9-7-,10-6+,18-13+/t17-/m0/s1
|
|||
| InChIKey |
VHRUMKCAEVRUBK-GODQJPCRSA-N
|
|||
| CAS Number |
CAS 87893-55-8
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
616280, 841874, 4265965, 7979704, 11056342, 12015428, 14718416, 14874531, 17395716, 26754842, 26754843, 26754844, 26754845, 26759405, 39340919, 47810521, 47885180, 47959481, 50110801, 53786796, 53790973, 56314447, 57359391, 80464931, 85787434, 92309777, 99300691, 99302209, 103640339, 104046458, 104115764, 114155556, 118046117, 126525348, 135651375, 143343420, 144229231, 163687448, 179205589, 184568145, 229217035, 241375873, 249617533, 252156430, 252363988, 252455501, 252457386, 252457388
|
|||
| ChEBI ID |
CHEBI:34159
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2692). | |||
| REF 2 | Expression of peroxisome proliferator-activated receptors (PPARs) in human urinary bladder carcinoma and growth inhibition by its agonists. Int J Cancer. 2003 May 1;104(5):597-602. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.